Insiders · Profile

KREHER NERISSA

Director at Rezolute · Chief Medical Officer at Entrada Therapeutics. Filing since 8 Sep 2022. CIK 0001741850

Company
Date
Role
Action
Shares
Amount
Of holding
13 Jun 2025
Director
Bought
3,076
$10.00K
8.9%
6 Sep 2023
Chief Medical Officer
Sold on a plan
892
$12.02K
2.2%
4 Aug 2023
Chief Medical Officer
Sold on a plan
6,898
$97.52K
20.3%
3 Aug 2023
Chief Medical Officer
Sold on a plan
9,464
$139.53K
25.9%
2 Aug 2023
Chief Medical Officer
Sold on a plan
10,348
$157.17K
27.6%
2 Mar 2023
Chief Medical Officer
Sold, plan not stated
1,641
$17.34K
3.8%
30 Dec 2022
Chief Medical Officer
Sold, plan not stated
5,200
$69.93K
25.1%
26 Oct 2022
Chief Medical Officer
Sold, plan not stated
4,960
$108.66K
19.3%
25 Oct 2022
Chief Medical Officer
Sold, plan not stated
8,040
$167.89K
28.0%
28 Sep 2022
Chief Medical Officer
Sold, plan not stated
3,122
$47.61K
13.1%
27 Sep 2022
Chief Medical Officer
Sold, plan not stated
2,403
$36.79K
10.4%
26 Sep 2022
Chief Medical Officer
Sold, plan not stated
3,068
$47.03K
12.9%
23 Sep 2022
Chief Medical Officer
Sold, plan not stated
939
$14.17K
4.3%
21 Sep 2022
Chief Medical Officer
Sold, plan not stated
3,341
$50.39K
13.9%
15 Sep 2022
Chief Medical Officer
Sold, plan not stated
106
$1.59K
0.5%
9 Sep 2022
Chief Medical Officer
Sold, plan not stated
800
$12.05K
3.7%
8 Sep 2022
Chief Medical Officer
Sold, plan not stated
1,221
$18.48K
5.6%
17 decisions on file.